BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 23782520)

  • 1. Efficacy of individualized homeopathic treatment and fluoxetine for moderate to severe depression in peri- and postmenopausal women (HOMDEP-MENOP): study protocol for a randomized, double-dummy, double-blind, placebo-controlled trial.
    Macías-Cortés Edel C; Aguilar-Faisal L; Asbun-Bojalil J
    Trials; 2013 Apr; 14():105. PubMed ID: 23782520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individualized homeopathic treatment and fluoxetine for moderate to severe depression in peri- and postmenopausal women (HOMDEP-MENOP study): a randomized, double-dummy, double-blind, placebo-controlled trial.
    Macías-Cortés Edel C; Llanes-González L; Aguilar-Faisal L; Asbun-Bojalil J
    PLoS One; 2015; 10(3):e0118440. PubMed ID: 25768800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is metabolic dysregulation associated with antidepressant response in depressed women in climacteric treated with individualized homeopathic medicines or fluoxetine? The HOMDEP-MENOP Study.
    Macías-Cortés ED; Llanes-González L; Aguilar-Faisal L; Asbun-Bojalil J
    Homeopathy; 2017 Feb; 106(1):3-10. PubMed ID: 28325221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homeopathy for depression--DEP-HOM: study protocol for a randomized, partially double-blind, placebo controlled, four armed study.
    Adler UC; Krüger S; Teut M; Lüdtke R; Bartsch I; Schützler L; Melcher F; Willich SN; Linde K; Witt CM
    Trials; 2011 Feb; 12():43. PubMed ID: 21320338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to Individualized Homeopathic Treatment for Depression in Climacteric Women with History of Domestic Violence, Marital Dissatisfaction or Sexual Abuse: Results from the HOMDEP-MENOP Study.
    Macías-Cortés EDC; Llanes-González L; Aguilar-Faisal L; Asbun-Bojalil J
    Homeopathy; 2018 Aug; 107(3):202-208. PubMed ID: 29871025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The feasibility of a randomised, placebo-controlled clinical trial of homeopathic treatment of depression in general practice.
    Katz T; Fisher P; Katz A; Davidson J; Feder G
    Homeopathy; 2005 Jul; 94(3):145-52. PubMed ID: 16060200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): study protocol for a randomised control trial.
    Davey CG; Chanen AM; Cotton SM; Hetrick SE; Kerr MJ; Berk M; Dean OM; Yuen K; Phelan M; Ratheesh A; Schäfer MR; Amminger GP; Parker AG; Piskulic D; Harrigan S; Mackinnon AJ; Harrison BJ; McGorry PD
    Trials; 2014 Nov; 15():425. PubMed ID: 25370185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ; Jiang Q
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venlafaxine vs. fluoxetine in postmenopausal women with major depressive disorder: an 8-week, randomized, single-blind, active-controlled study.
    Zhou J; Wang X; Feng L; Xiao L; Yang R; Zhu X; Shi H; Hu Y; Chen R; Boyce P; Wang G
    BMC Psychiatry; 2021 May; 21(1):260. PubMed ID: 34011310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoxetine versus placebo in posttraumatic stress disorder.
    Martenyi F; Brown EB; Zhang H; Prakash A; Koke SC
    J Clin Psychiatry; 2002 Mar; 63(3):199-206. PubMed ID: 11926718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes.
    March JS; Silva S; Petrycki S; Curry J; Wells K; Fairbank J; Burns B; Domino M; McNulty S; Vitiello B; Severe J
    Arch Gen Psychiatry; 2007 Oct; 64(10):1132-43. PubMed ID: 17909125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.
    March J; Silva S; Petrycki S; Curry J; Wells K; Fairbank J; Burns B; Domino M; McNulty S; Vitiello B; Severe J;
    JAMA; 2004 Aug; 292(7):807-20. PubMed ID: 15315995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous administration of adenosine triphosphate and phosphocreatine combined with fluoxetine in major depressive disorder: protocol for a randomized, double-blind, placebo-controlled pilot study.
    Chen Y; Cao X; Zang W; Tan S; Ou CQ; Shen X; Gao T; Zhao L
    Trials; 2019 Jan; 20(1):34. PubMed ID: 30626424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retraction: Individualized Homeopathic Treatment and Fluoxetine for Moderate to Severe Depression in Peri- and Postmenopausal Women (HOMDEP-MENOP Study): A Randomized, Double-Dummy, Double-Blind, Placebo-Controlled Trial.
    PLOS ONE Editors
    PLoS One; 2020; 15(4):e0232415. PubMed ID: 32324840
    [No Abstract]   [Full Text] [Related]  

  • 15. Correction: Individualized Homeopathic Treatment and Fluoxetine for Moderate to Severe Depression in Peri- and Postmenopausal Women (HOMDEP-MENOP Study): A Randomized, Double-Dummy, Double-Blind, Placebo-Controlled Trial.
    PLOS ONE Staff
    PLoS One; 2015; 10(5):e0127719. PubMed ID: 25938465
    [No Abstract]   [Full Text] [Related]  

  • 16. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
    Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
    J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homeopathic Individualized Q-Potencies versus Fluoxetine for Moderate to Severe Depression: Double-Blind, Randomized Non-Inferiority Trial.
    Adler UC; Paiva NM; Cesar AT; Adler MS; Molina A; Padula AE; Calil HM
    Evid Based Complement Alternat Med; 2011; 2011():520182. PubMed ID: 19687192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Homeopathy in Addition to a Multidisciplinary Intervention for Overweight or Obesity in Mexican Adolescents: Study Protocol for a Randomized, Double-Blind, Placebo-Controlled Trial.
    Macías-Cortés E; Arellano-Álvarez S; Vega-Monroy S; Vera-Pérez V; Llanes-González L; Sánchez-Navarrete P; Enciso-González D
    Homeopathy; 2020 May; 109(2):87-96. PubMed ID: 31958867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, placebo-controlled study of venlafaxine and fluoxetine in geriatric outpatients with major depression.
    Schatzberg A; Roose S
    Am J Geriatr Psychiatry; 2006 Apr; 14(4):361-70. PubMed ID: 16582045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.